AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Glioma

Showing 251 to 260 of 340 articles

Clear Filters

Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI.

Journal of magnetic resonance imaging : JMRI
BACKGROUND: There are concerns over gadolinium deposition from gadolinium-based contrast agents (GBCA) administration.

MRI radiomics analysis of molecular alterations in low-grade gliomas.

International journal of computer assisted radiology and surgery
PURPOSE: Low-grade gliomas (LGG) are classified into three distinct groups based on their IDH1 mutation and 1p/19q codeletion status, each of which is associated with a different clinical expression. The genomic sub-classification of LGG requires tum...

A novel fully automatic multilevel thresholding technique based on optimized intuitionistic fuzzy sets and tsallis entropy for MR brain tumor image segmentation.

Australasian physical & engineering sciences in medicine
In the present paper, a hybrid multilevel thresholding technique that combines intuitionistic fuzzy sets and tsallis entropy has been proposed for the automatic delineation of the tumor from magnetic resonance images having vague boundaries and poor ...

Glioma Survival Prediction with Combined Analysis of In Vivo C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Gliomas are the most common type of tumor in the brain. Although the definite diagnosis is routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of patients with suspected glioma is mainly done using MRI. Nevertheles...

Residual Convolutional Neural Network for the Determination of Status in Low- and High-Grade Gliomas from MR Imaging.

Clinical cancer research : an official journal of the American Association for Cancer Research
Isocitrate dehydrogenase () mutations in glioma patients confer longer survival and may guide treatment decision making. We aimed to predict the status of gliomas from MR imaging by applying a residual convolutional neural network to preoperative r...

Interactive phenotyping of large-scale histology imaging data with HistomicsML.

Scientific reports
Whole-slide imaging of histologic sections captures tissue microenvironments and cytologic details in expansive high-resolution images. These images can be mined to extract quantitative features that describe tissues, yielding measurements for hundre...

MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.

NeuroImage. Clinical
BACKGROUND: P53 mutation status is a pivotal biomarker for gliomas. Here, we developed a machine-learning model to predict p53 status in lower-grade gliomas based on radiomic features extracted from conventional magnetic resonance (MR) images.

Multi-label Inductive Matrix Completion for Joint MGMT and IDH1 Status Prediction for Glioma Patients.

Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention
MGMT promoter methylation and IDH1 mutation in high-grade gliomas (HGG) have proven to be the two important molecular indicators associated with better prognosis. Traditionally, the statuses of MGMT and IDH1 are obtained via surgical biopsy, which is...

Brain tumor segmentation using holistically nested neural networks in MRI images.

Medical physics
PURPOSE: Gliomas are rapidly progressive, neurologically devastating, largely fatal brain tumors. Magnetic resonance imaging (MRI) is a widely used technique employed in the diagnosis and management of gliomas in clinical practice. MRI is also the st...

Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma.

Scientific reports
Deep learning-based radiomics (DLR) was developed to extract deep information from multiple modalities of magnetic resonance (MR) images. The performance of DLR for predicting the mutation status of isocitrate dehydrogenase 1 (IDH1) was validated in ...